Literature DB >> 23005574

Treating alcoholism reduces financial burden on care-givers and increases quality-adjusted life years.

Hans Joachim Salize1, Christian Jacke, Sven Kief, Michael Franz, Karl Mann.   

Abstract

AIMS: The study assessed the alcoholism-related financial burden borne by informal care-givers and relatives of German alcoholic patients.
DESIGN: By using an exploratory approach, care-giver burden was assessed both prior to and 12 months after detoxification and withdrawal. Quality-of-life data for care-givers collected during follow-up were used to calculate the number of quality-adjusted life years (QALYs) gained by alcoholics' family members while their relatives are undergoing treatment. PARTICIPANTS: Forty-eight informal care-givers and relatives of alcoholic patients.
SETTING: In-patient and out-patient departments of three psychiatric university hospitals in Germany. MEASUREMENTS: Expenditures of families related directly to the addiction disorder of alcoholic patients, quality of life of care-givers, relapses of patients.
FINDINGS: Families' expenditures related directly to their addicted member's alcoholism decreased from an average of €676.44 per month (or 20.2% of the total pre-tax family income) at baseline to an average of €145.40 per month at 12 months after the beginning of treatment. The average time spent caring for the affected family member was reduced from 32.3 hours per month to 8.2 hours per month (P = 0.0109), and quality-of-life total scores increased from 60.6 to 68.0. The total gain in QALYs for family members was 0.108. When weighed against the average cost of the alcoholism treatment, the cost of one QALY for care-giving family members was €20,398 on average.
CONCLUSIONS: Among the families of German alcoholics who receive detoxification, there is a substantial reduction in family expenditures, time spent caring and an increase in quality of life at 1 year. These are important but often neglected additional measures of the burden on family members and also treatment benefits.
© 2012 The Authors, Addiction © 2012 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2012        PMID: 23005574     DOI: 10.1111/j.1360-0443.2012.04002.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

1.  [Normative definition of staff requirement for a guideline-adherent inpatient qualified detoxification treatment in alcohol dependence].

Authors:  F Kiefer; A Koopmann; F Godemann; J Wolff; A Batra; K Mann
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

Review 2.  The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.

Authors:  Michael Sonntag; Hans-Helmut König; Alexander Konnopka
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

3.  Caregiving for Relatives with Psychiatric Disorders vs. Co-Occurring Psychiatric and Substance Use Disorders.

Authors:  Travis Labrum
Journal:  Psychiatr Q       Date:  2018-09

4.  A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.

Authors:  Nadja Klafke; Cornelia Mahler; Cornelia von Hagens; Justine Rochon; Andreas Schneeweiss; Andreas Müller; Hans-Joachim Salize; Stefanie Joos
Journal:  Trials       Date:  2015-02-15       Impact factor: 2.279

5.  Health Utility of Drinkers' Family Members: A Secondary Analysis of a US Population Data Set.

Authors:  Benjamin Thornburg; Jeremy W Bray; Eve Wittenberg
Journal:  MDM Policy Pract       Date:  2022-09-27

6.  Perceived quality of life in partners of patients undergoing treatment in somatic health, mental health, or substance use disorder units: a cross-sectional study.

Authors:  Bente Birkeland; Bente M Weimand; Torleif Ruud; Magnhild M Høie; John-Kåre Vederhus
Journal:  Health Qual Life Outcomes       Date:  2017-08-30       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.